Dyslipidemias: all 1,101 studies
Page 7 of 12. Open to participants first (161), then studies with results posted, then the rest; newest registration first within each.
- RiSE to Prevent Cardiovascular Disease in African AmericansCompletedNCT03878290Not applicable
- Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin MonotherapyStatus unknownNCT03874260Phase 4
- BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.Status unknownNCT03867942Phase 1
- GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONALCompletedNCT03861533
- The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/RosuvastatinCompletedNCT03860220Phase 4
- The Effect of Childhood Dyslipidemia on Endothelial and Renal FunctionCompletedNCT03856476
- Dark Chocolate, Cholesterol and MicrobiotaStatus unknownNCT03850405Not applicable
- The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters.Status unknownNCT03850314Phase 2/3
- Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male AdultsStatus unknownNCT03849287Phase 1
- Exploring the Comorbidity Between Mental Disorders and General Medical ConditionsCompletedNCT03847753
- Intermittent Fasting in DyslipidemiaStatus unknownNCT03805776Not applicable
- Role of Ajwa Derived Polyphenols in DyslipidaemiasStatus unknownNCT03805139Not applicable
- Comparative Analysis of Serum Lipid Profiles in Patients With and Without GallstonesCompletedNCT03804775
- Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian PopulationCompletedNCT03799185
- Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALICompletedNCT03795038Not applicable
- Type 2 Diabetic Patients Maintained on Statin TherapyCompletedNCT03784703Phase 4
- Ulmus Macrocarpa Hance Extract and Lipid ProfileCompletedNCT03773315Not applicable
- Early Alirocumab to Reduce LDL-C in Myocardial InfarctionWithdrawnNCT03750760Phase 4
- Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic PatientsCompletedNCT03747224Phase 1
- Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and EfficacyStatus unknownNCT03742544
- Peru Longitudinal StudyTerminatedNCT03742219Not applicable
- Personal Activity Intelligence (PAI) PilotCompletedNCT03740074Not applicable
- Evaluation of a Lifestyle Medicine PracticeCompletedNCT03739034Not applicable
- Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With DyslipidemiaCompletedNCT03730038Not applicable
- Lifestyle Interventions and Metabolic Profile in Obese ChildrenCompletedNCT03728621Not applicable
- A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy SubjectsStatus unknownNCT03726866Phase 1
- Correlation of Serum Adropin to Testosterone and Adiponectin in Obese MenCompletedNCT03724825
- Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCICompletedNCT03718286Phase 2
- The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers VolunteersCompletedNCT03707899Phase 1
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican PopulationStatus unknownNCT03696940Phase 3
- Research on Burden of Disease for Patients With Myocardial Infarction Combining Dyslipidemia in ChinaStatus unknownNCT03691246
- Efficacy and Safety of Nutraceuticals in Patients With Diabetes Mellitus Type II and Dyslipidemia.CompletedNCT03676309Phase 2
- Effect of Adding Folic Acid on Lipid Parameters in Population With DyslipidemiasStatus unknownNCT03674333Not applicable
- Determinants of Cognitive Impairment Among GeriatricsStatus unknownNCT03669536
- Pharmacokinetics and Safety Profile of CKD-333CompletedNCT03659149Phase 1
- A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.Status unknownNCT03648801
- A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/EzetimibeStatus unknownNCT03648788
- Zinc Supplement Before or With Food in Generally Healthy MenCompletedNCT03619421Not applicable
- A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemiaCompletedNCT03618797Phase 3
- A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male SubjectsCompletedNCT03609606Phase 1
- Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy StudyStatus unknownNCT03607383Phase 2
- Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)Status unknownNCT03606824Not applicable
- Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 TabletCompletedNCT03583905Phase 3
- Efficacy and Safety of Cipros 20 Association on Dyslipidemia TreatmentCompletedNCT03540355Phase 3
- China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and HypertensionStatus unknownNCT03532620Phase 4
- Dietary Approaches for Cardiometabolic HealthCompletedNCT03527290Not applicable
- Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia TreatmentCompletedNCT03527069Phase 3
- Pharmacist-led Medication Review With Follow-up on Primary Care Cardiovascular Older Adult Patients.CompletedNCT03502109Not applicable
- Compliance With The European Society Of Cardiology Prevention Guidelines In Patients at High Cardiovascular Disease RiskStatus unknownNCT03483155
- Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly ControlledCompletedNCT03482180Phase 3
- Evaluation of Zinc Intake on Essential Fatty Acid MetabolismCompletedNCT03451214Not applicable
- Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver DiseaseCompletedNCT03434613Phase 4
- Levels of Triglycerides and HDL-C in ACS PatientsStatus unknownNCT03429517
- Safety and Efficacy of Statins for Chinese Patients With DyslipidemiaStatus unknownNCT03418974Phase 4
- Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent MannerCompletedNCT03415503Phase 3
- Efficacy of Fixed-doses of Antihypertensive and Statin DrugsWithdrawnNCT03401580Phase 2
- A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337CompletedNCT03382756Phase 1
- Effects of Psyllium on Niacin TolerabilityCompletedNCT03370848Phase 4
- The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.CompletedNCT03367663Early Phase 1
- A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337CompletedNCT03346187Phase 1
- A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03338426Phase 3
- PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENTCompletedNCT03329729
- The Influence of Pilates Exercises Training Volume on Metabolic Outcomes in Dyslipidemic Women.CompletedNCT03307031Not applicable
- Fatty Acid Biomarkers of Carbohydrate IntakeCompletedNCT03295448Not applicable
- The Effectiveness of Smart Health Management Program for Patients With Chronic IllnessCompletedNCT03294044Not applicable
- Quinoa Biscuit & CVD Risk TrialCompletedNCT03291548Not applicable
- Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol EsterCompletedNCT03284918Not applicable
- Circulating Non-coding RNAs and Cardiovascular Outcomes in Patients With Dyslipidemia and AtherosclerosisStatus unknownNCT03279770
- Thyroid Dysfunction and Dyslipidemia in Patients With Chronic Kidney DiseasesStatus unknownNCT03277911
- Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With HypertensionCompletedNCT03267329Phase 4
- Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and HypertensionStatus unknownNCT03254446Phase 3
- Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological SuppressionCompletedNCT03251690Not applicable
- The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers VolunteersCompletedNCT03247140Phase 1
- Study of Eating Patterns with a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic SyndromeCompletedNCT03241121Not applicable
- A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706CompletedNCT03235362Phase 1
- Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical TrialCompletedNCT03221816Phase 4
- Prospective Observational Study of Pravafenix CapStatus unknownNCT03214211
- Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519CompletedNCT03210649Phase 1
- Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and DyslipidemiaCompletedNCT03210532Phase 3
- Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)CompletedNCT03207945Phase 3
- Metagenomic Analysis of Human Gut Microbiota in Patients With Metabolic Diseases Including DiabetesStatus unknownNCT03204799
- Metabolic Response to Chardonnay Grape Marc PowderCompletedNCT03203915Not applicable
- The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown CohortCompletedNCT03191227
- Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male SubjectsCompletedNCT03175835Phase 1
- Relation Between Postprandial Lipogram and Coronary Artery Disease SeverityStatus unknownNCT03175393
- Effects of Exercise on Fructose-induced Postprandial LipemiaCompletedNCT03173495Not applicable
- Implementing and Testing a Cardiovascular Assessment Screening Program (CASP)CompletedNCT03170752Not applicable
- Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health TechnologyCompletedNCT03167996Not applicable
- Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03156842Phase 3
- COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected PatientsCompletedNCT03139630
- Vitamin D Supplementation for Treatment of DyslipidemiaStatus unknownNCT03133975Phase 3
- Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication RegistryCompletedNCT03110432
- Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight WomenCompletedNCT03109834Phase 3
- Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dLSuspendedNCT03097107Phase 2
- Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/RosuvastatinCompletedNCT03088254Phase 3
- A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 DiabetesCompletedNCT03068078Not applicable
- POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 DiabetesStatus unknownNCT03047668Not applicable
- Fixed Combination for Lipid and Blood Pressure ControlWithdrawnNCT03047538Phase 4
- Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic SubjectsCompletedNCT03027336Phase 2
- Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly ControlledCompletedNCT03026933Phase 3